Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Large Granular Lymphocytic × Brentuximab Vedotin × 90 days × Clear all

Sponsor

Conditions

Hodgkin Disease 5 Mycosis Fungoides 2 Lymphoma 2 Squamous Cell Carcinoma of Head and Neck 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Melanoma 1 Lymphomatoid Papulosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Primary Cutaneous Anaplastic Large Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hematologic Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

thymoglobulin 1 siltuximab 1 ruxolitinib 1 fludarabine phosphate 1 fludarabine 1 cc-486 1 blinatumomab 1 Valganciclovir 1 Thiotepa 1 Therapeutics 1 Polymerase Chain Reaction 1 Mesna 1 Melphalan 1 Interleukin-6 1 Granulocyte Colony-Stimulating Factor 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Filgrastim 1 Cyclophosphamide 1 Azacitidine 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡